方法应用ELISA法检测46例NSCLC,19例肺良性病变者(Benign lung diseases,BLD)及60例健康人血清GST-π含量,对46例NSCLC患者行诺维本加顺铂方案化疗两周期并判断疗效。
基于8个网页-相关网页
结果 67例肺癌患者CEA-mRNA阳性率59.7%,25例肺部良性疾病(benign lung diseases,BLD)患者阳性率16.0%,37例健康对照者阳性率2.7%,肺癌组与BLD组、健康对照组间差异均有显著性(...
基于8个网页-相关网页
方法应用ELISA法检测46例NSCLC,19例肺良性病变者(Benign lung diseases,BLD)及60例健康人血清GST-π含量,对46例NSCLC患者行诺维本加顺铂方案化疗两周期并判断疗效。
基于8个网页-相关网页
方法应用ELISA法检测46例NSCLC,19例肺良性病变者(Benign lung diseases,BLD)及60例健康人血清GST-π含量,对46例NSCLC患者行诺维本加顺铂方案化疗两周期并判断疗效。
基于8个网页-相关网页
In 16 patients with benign lung diseases, no recurrences and late complications were found.
肺良性病变16例，无复发及远期合并症。
In patients with benign lung diseases, perioperative changes were slight and non-significant.
良性疾病患者手术前后无显著性差异。
Methods Serum levels of endostatin were measured by an enzyme-linked immunosorbent assay (ELISA) in 44 patients with lung cancer, 20 patients with benign lung diseases and 20 normal persons.
方法应用酶联免疫吸附试验(ELISA法)，测定44例原发性肺癌、20例肺部良性疾病和20例正常人血清内皮抑素含量。
应用推荐